Drug-Induced Cholestasis

被引:45
作者
Bhamidimarri, Kalyan Ram [1 ]
Schiff, Eugene [1 ]
机构
[1] Univ Miami, Miami, FL 33136 USA
关键词
Drugs; Cholestasis; Liver injury; Bile duct injury; Management; INDUCED LIVER-INJURY; BILE-DUCT SYNDROME; INFLAMMATORY-BOWEL-DISEASE; SALT EXPORT PUMP; INTRAHEPATIC CHOLESTASIS; CAUSALITY ASSESSMENT; ORAL MEDICATIONS; UNITED-STATES; CASE-SERIES; HEPATOTOXICITY;
D O I
10.1016/j.cld.2013.07.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Drug-induced cholestasis manifests as an acute self-limiting injury or as a chronic perpetuating injury, resulting in duct loss and cirrhosis. The number of drugs implicated in drug-induced cholestasis grows every year as new drugs are developed and approved. Other agents such as herbals, nutritional supplements, and complementary and alternative medicines are also reported to cause cholestatic liver injury. Recent literature on molecular transporters involved in bile transport has improved our understanding of patterns of drug-induced liver injury and the mechanisms of cholestasis. This article summarizes the probable offending drugs and the diagnosis and management of drug-induced cholestasis.
引用
收藏
页码:519 / +
页数:14
相关论文
共 60 条
[1]   Terbinafine and fulminant hepatic failure [J].
Agarwal, K ;
Manas, DM ;
Hudson, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) :1292-1293
[2]  
Akhtar AJ, 2007, J NATL MED ASSOC, V99, P1381
[3]   Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry [J].
Andrade, Raul J. ;
Lucena, M. Isabel ;
Kaplowitz, Neil ;
Garcia-Munoz, Beatriz ;
Borraz, Yolanda ;
Pachkoria, Ketevan ;
Garcia-Cortes, Miren ;
Fernandez, M. Carmen ;
Pelaez, Gloria ;
Rodrigo, Luis ;
Duran, Jose A. ;
Costa, Joan ;
Planas, Ramon ;
Barriocanal, Anabel ;
Guarner, Carlos ;
Romero-Gomez, Manuel ;
Munoz-Yague, Teresa ;
Salmeron, Javier ;
Hidalgo, Ramon .
HEPATOLOGY, 2006, 44 (06) :1581-1588
[4]   Hepatic safety of antibiotics used in primary care [J].
Andrade, Raul J. ;
Tulkens, Paul M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (07) :1431-1446
[5]   Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[6]   HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease [J].
Andrade, RJ ;
Lucena, MI ;
Alonso, A ;
García-Cortes, M ;
García-Ruiz, E ;
Benitez, R ;
Fernández, MC ;
Pelaez, G ;
Romero, M ;
Corpas, R ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Nogueras, F ;
Martín-Vivaldi, R ;
Navarro, JM ;
Salmerón, J ;
de la Cuesta, FS ;
Hidalgo, R .
HEPATOLOGY, 2004, 39 (06) :1603-1612
[7]  
Andrade RJ, 2001, ANN PHARMACOTHER, V35, P783
[8]   Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease [J].
Bastida, G ;
Nos, P ;
Aguas, M ;
Beltrán, B ;
Rubín, A ;
Dasí, F ;
Ponce, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (09) :775-782
[9]   Suspected drug-induced liver fatalities reported to the WHO database [J].
Björnsson, E ;
Olsson, R .
DIGESTIVE AND LIVER DISEASE, 2006, 38 (01) :33-38
[10]   Drug-Induced Cholestasis [J].
Bjornsson, Einar S. ;
Jonasson, Jon Gunnlaugur .
CLINICS IN LIVER DISEASE, 2013, 17 (02) :191-+